Precigen (PGEN)
(Delayed Data from NSDQ)
$3.12 USD
-0.07 (-2.19%)
Updated Oct 10, 2025 04:00 PM ET
After-Market: $3.10 -0.02 (-0.64%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PGEN 3.12 -0.07(-2.19%)
Will PGEN be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for PGEN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PGEN
INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease Drug
PGEN Stock Surges 144% in August on FDA Nod for Rare Lung Disease Drug
PGEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates
Generation Bio Co. (GBIO) Reports Q4 Loss, Tops Revenue Estimates
Precigen, Inc. (PGEN) Just Flashed Golden Cross Signal: Do You Buy?
Other News for PGEN
PGEN falls 2.19% on October 10, leaving the technical picture intact
PGEN forms NR7 on October 9
Is PGEN positioned for a breakdown? Fell Below 50 Day Moving Average shows up after sliding 2.72%
PGEN Crossed Above 50 Day Moving Average on October 7
PGEN Fell Below 50 Day Moving Average on October 6